secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001999371-24-002423
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tonix shareholders approve issuance of up to 162M shares upon warrant exercise
------------------------------------------------------------------------------

- Shareholders approved up to 162,162,162 shares issuable upon exercise of Series C and D warrants.
- Vote: 7,560,035 for, 1,453,119 against, 57,620 abstentions.
- 9,070,774 shares (33.9% of outstanding) represented at Feb 15, 2024 special meeting.
- Adjournment proposal also approved: 7,553,051 for, 1,388,810 against.
- Warrants issued in Dec 22, 2023 offering; approval needed for Nasdaq Listing Rule 5635(d).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937124002423/0001999371-24-002423-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937124002423/tnxp-8k_021524.htm
  HTML page:      https://secwatch.observer/filing/0001999371-24-002423

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer